Market Exclusive

Analyst Activity – BMO Capital Markets Raises Its Price Target On Celgene Corporation (NASDAQ:CELG) to $160.00

Analyst Ratings For Celgene Corporation (NASDAQ:CELG)

Today, BMO Capital Markets raised its price target on Celgene Corporation (NASDAQ:CELG) to $160.00 per share.

There are 1 sell rating, 5 hold ratings, 20 buy ratings on the stock.

The current consensus rating on Celgene Corporation (NASDAQ:CELG) is Buy (Score: 2.73) with a consensus target price of $142.75 per share, a potential 6.45% upside.

Some recent analyst ratings include

Recent Insider Trading Activity For Celgene Corporation (NASDAQ:CELG)
Celgene Corporation (NASDAQ:CELG) has insider ownership of 0.95% and institutional ownership of 78.39%.

Recent Trading Activity for Celgene Corporation (NASDAQ:CELG)
Shares of Celgene Corporation closed the previous trading session at 134.10 down -0.05 -0.04% with 3,771,910 shares trading hands.

Exit mobile version